Jennifer L. Mitcham - Redmond WA Gordon E. King - Seattle WA Paul A. Algate - Issaquah WA Steven P. Fling - Bainbridge Island WA Marc W. Retter - Carnation WA Gary R. Fanger - Mill Creek WA Steven G. Reed - Bellevue WA Thomas S. Vedvick - Federal Way WA Darrick Carter - Seattle WA
Assignee:
Corixa Corporation - Seattle WA
International Classification:
C12Q 168
US Classification:
435 6, 4352523, 4353201, 435325, 536 231, 536 241
Abstract:
Compositions and methods for the therapy and diagnosis of cancer, such as ovarian cancer, are disclosed. Compositions may comprise one or more ovarian carcinoma proteins, immunogenic portions thereof, polynucleotides that encode such portions or antibodies or immune system cells specific for such proteins. Such compositions may be used, for example, for the prevention and treatment of diseases such as ovarian cancer. Methods are further provided for identifying tumor antigens that are secreted from ovarian carcinomas and/or other tumors. Polypeptides and polynucleotides as provided herein may further be used for the diagnosis and monitoring of ovarian cancer.
Compositions And Methods For The Therapy And Diagnosis Of Ovarian Cancer
Jiangchun Xu - Bellevue WA John A. Stolk - Bothell WA Paul A. Algate - Issaquah WA Steven P. Fling - Bainbridge Island WA
Assignee:
Corixa Corporation - Seattle WA
International Classification:
C07H 2100
US Classification:
536 231, 536 243, 536 253, 4353201, 435325
Abstract:
Compositions and methods for the therapy and diagnosis of cancer, particularly ovarian cancer, are disclosed. Illustrative compositions comprise one or more ovarian tumor polypeptides, immunogenic portions thereof, polynucleotides that encode such polypeptides, antigen presenting cell that expresses such polypeptides, and T cells that are specific for cells expressing such polypeptides. The disclosed compositions are useful, for example, in the diagnosis, prevention and/or treatment of diseases, particularly ovarian cancer.
Compositions And Methods For The Therapy And Diagnosis Of Ovarian Cancer
Jennifer L. Mitcham - Redmond WA, US Gordon E. King - Shoreline WA, US Paul A. Algate - Issaquah WA, US
Assignee:
Corixa Corporation - Seattle WA
International Classification:
C07K016/00 C12P021/08
US Classification:
5303871, 5303877, 5303881
Abstract:
Compositions and methods for the therapy and diagnosis of cancer, such as ovarian cancer, are disclosed. Compositions may comprise one or more ovarian carcinoma proteins, immunogenic portions thereof, polynucleotides that encode such portions or antibodies or immune system cells specific for such proteins. Such compositions may be used, for example, for the prevention and treatment of diseases such as ovarian cancer. Methods are further provided for identifying tumor antigens that are secreted from ovarian carcinomas and/or other tumors. Polypeptides and polynucleotides as provided herein may further be used for the diagnosis and monitoring of ovarian cancer.
Compositions And Methods For The Therapy And Diagnosis Of Ovarian Cancer
Jennifer L. Mitcham - Redmond WA, US Gordon E. King - Seattle WA, US Paul A. Algate - Issaquah WA, US Steven P. Fling - Bainbridge Island WA, US Marc W. Retter - Carnation WA, US Gary R. Fanger - Mill Creek WA, US Steven G. Reed - Bellevue WA, US
Compositions and methods for the therapy and diagnosis of cancer, such as ovarian cancer, are disclosed. Compositions may comprise one or more ovarian carcinoma proteins, immunogenic portions thereof, polynucleotides that encode such portions or antibodies or immune system cells specific for such proteins. Such compositions may be used, for example, for the prevention and treatment of diseases such as ovarian cancer. Methods are further provided for identifying tumor antigens that are secreted from ovarian carcinomas and/or other tumors. Polypeptides and polynucleotides as provided herein may further be used for the diagnosis and monitoring of ovarian cancer.
Compositions And Methods For The Detection, Diagnosis And Therapy Of Hematological Malignancies
Alexander Gaiger - Vienna, AT Paul A. Algate - Issaquah WA, US Jane Mannion - Newbury Park CA, US Jonathan D. Clapper - University Place WA, US Aijun Wang - Issaquah WA, US Nadia Ordonez - Seattle WA, US Lauren Carter - Seattle WA, US Patricia Dianne McNeill - Federal Way WA, US
Assignee:
Corixa Corporation - Seattle WA
International Classification:
C12P 21/08
US Classification:
5303881
Abstract:
Disclosed are methods and compositions for the detection, diagnosis, prognosis, and therapy of hematological malignancies, and in particular, B cell leukemias, lymphomas and multiple myelomas. Disclosed are compositions, methods and kits for eliciting immune and T cell responses to specific malignancy-related antigenic polypeptides and antigenic polypeptide fragments thereof in an animal. Also disclosed are compositions and methods for use in the identification of cells and biological samples containing one or more hematological malignancy-related compositions, and methods for the detection and diagnosis of such diseases and affected cell types. Also disclosed are diagnostic and therapeutic kits, as well as methods for the diagnosis, therapy and/or prevention of a variety of leukemias and lymphomas.
Compositions And Methods For The Therapy And Diagnosis Of Ovarian Cancer
Compositions and methods for the therapy and diagnosis of cancer, such as ovarian cancer, are disclosed. Compositions may comprise one or more ovarian tumor proteins, immunogenic portions thereof, or polynucleotides that encode such portions. Alternatively, a therapeutic composition may comprise an antigen presenting cell that expresses an ovarian tumor protein, or a T cell that is specific for cells expressing such a protein. Such compositions may be used, for example, for the prevention and treatment of diseases such as ovarian cancer. Diagnostic methods based on detecting an ovarian tumor protein, or mRNA encoding such a protein, in a sample are also provided.
Compositions And Methods For The Therapy And Diagnosis Of Ovarian Cancer
Jiangchun Xu - Bellevue WA, US Jennifer Mitcham - Redmond WA, US Susan Harlocker - Seattle WA, US Davin Dillon - Issaquah WA, US Heather Secrist - Seattle WA, US Michael Lodes - Seattle WA, US Paul Algate - Issaquah WA, US Steven Fling - Bainbridge Island WA, US Jane Mannion - Edmonds WA, US Darin Benson - Seattle WA, US Darrick Carter - Seattle WA, US
Compositions and methods for the therapy and diagnosis of cancer, such as ovarian cancer, are disclosed. Compositions may comprise one or more ovarian tumor proteins, immunogenic portions thereof, or polynucleotides that encode such portions. Alternatively, a therapeutic composition may comprise an antigen presenting cell that expresses an ovarian tumor protein, or a T cell that is specific for cells expressing such a protein. Such compositions may be used, for example, for the prevention and treatment of diseases such as ovarian cancer. Diagnostic methods based on detecting an ovarian tumor protein, or mRNA encoding such a protein, in a sample are also provided.
Compositions And Methods For The Therapy And Diagnosis Of Lung Cancer
Steven Reed - Bellevue WA, US Michael Lodes - Seattle WA, US Raodoh Mohamath - Seattle WA, US Heather Secrist - Seattle WA, US Darin Benson - Seattle WA, US Carol Indirias - Seattle WA, US Robert Henderson - Edmonds WA, US Steven Fling - Bainbridge Island WA, US Paul Algate - Issaquah WA, US Mark Elliott - Seattle WA, US Jane Mannion - Edmonds WA, US Michael Kalos - Seattle WA, US
Compositions and methods for the therapy and diagnosis of cancer, particularly lung cancer, are disclosed. Illustrative compositions comprise one or more lung tumor polypeptides, immunogenic portions thereof, polynucleotides that encode such polypeptides, antigen presenting cell that expresses such polypeptides, and T cells that are specific for cells expressing such polypeptides. The disclosed compositions are useful, for example, in the diagnosis, prevention and/or treatment of diseases, particularly lung cancer.
Sound Biologics
Senior Director, Biology
Oncoresponse 2016 - 2018
Director Biology
Theraclone Sciences Jun 2013 - 2016
Director, Biology
Emergent Biosolutions Oct 2010 - 2013
Director, Non-Clinical Research
Trubion Pharmaceuticals, Inc 2006 - Oct 2010
Senior Scientist and Director, Research
Education:
The Brody School of Medicine at East Carolina University
Doctorates, Doctor of Philosophy, Microbiology, Immunology
Skills:
Immunology Biotechnology Biopharmaceuticals Cell Drug Discovery Lifesciences Molecular Biology Monoclonal Antibodies Technology Transfer Vaccines Drug Development Cancer Assay Development Oncology Infectious Diseases Flow Cytometry Validation Elisa Life Sciences Strategic Alliances and Partner Development Genomics Pharmaceutical Industry Clinical Trials Clinical Development Ind Immunoassays Antibodies